COMMUNIQUÉS West-GlobeNewswire

NICOX : Number of voting rights as of January 31, 2018
01/02/2018
Nicox SA Société anonyme with a registered capital of € 29,459,338 Head Office: DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642 On February 1, 2018, MONTHLY PUBLICATION OF THE [...]
NICOX : Nombre de droits de vote au 31 janvier 2018
01/02/2018
Nicox SA Société anonyme au capital de 29 459 338 euros Siège social : DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642 Le 1er février 2018, PUBLICATION MENSUELLE DU NOMBRE D' [...]
New Chief Human Resources Officer Joins Corizon Health
01/02/2018
BRENTWOOD, Tenn., Feb. 01, 2018 (GLOBE NEWSWIRE) -- Carolyn Schneider has joined Corizon Health as its Chief Human Resources Officer, CEO Steve Rector announced. “Carolyn’s extensive experience in integrating workforces [...]
Alder BioPharmaceuticals, Inc. Announces Closing of $250 Million of 2.50% Convertible Senior Notes Due 2025
01/02/2018
BOTHELL, Wash., Feb. 01, 2018 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ: ALDR ), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, announced [...]
Insider tradings
01/02/2018
Nasdaq Copenhagen 1 February 2018 Report on transactions of executives and related parties in Coloplast shares and related securities According to the Market Abuse Regulation art. 19 Coloplast is obliged to report on [...]
Intercept Announces Updated U.S. Prescribing Information for Ocaliva® (obeticholic acid) to Reinforce Appropriate Dosing in PBC Patients with Advanced Cirrhosis
01/02/2018
NEW YORK, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT ), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non- [...]
Endonovo Reports Pre-Clinical Data Demonstrating Immunotronics™ Reduced Infarct Size and Inhibited Fibrosis following Myocardial Infarction
01/02/2018
LOS ANGELES, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of non-invasive wearable Electroceutical™ devices, today announced [...]
Wildflower Closes on $2 Million Private Placement to Meet Massive California Demand
01/02/2018
VANCOUVER, British Columbia, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Wildflower Marijuana Inc. (CSE:SUN) (the " Company ") is pleased to announce a private placement of units (“ Units ”) at a price of C$1.50 per Unit for [...]
Shire plc : Notice of Results
01/02/2018
Shire to announce full year 2017 results Dublin, Ireland - February 1, 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG), will announce full year 2017 earnings on Wednesday February 14, 2018. Results press release will be [...]
Nuvectra™ Announces Pricing of Follow-On Stock Offering
01/02/2018
PLANO, Texas, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR ), a neurostimulation medical device company, announced today the pricing of its underwritten follow-on public offering of 2,825,000 [...]
Predictive Technology Group, Inc. (PRED) Appoints Ronald Barhorst to Chair Its Financial Advisory Board
01/02/2018
SALT LAKE CITY, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Predictive Technology Group, Inc. (OTC PINK:PRED), a leader in the use of data analytics for disease identification and subsequent therapeutic intervention through [...]
INSYS Therapeutics Appoints Vaseem Mahboob to Board of Directors
01/02/2018
PHOENIX, Feb. 01, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY ), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, today announced [...]
Abattis Enters Into Definitive Agreement to Acquire 49% Stake In CannaNUMUS Blockchain
01/02/2018
VANCOUVER, British Columbia, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp. (the "Company" or "Abattis") (CSE:ATT) (OTC:ATTBF) is pleased to announce that it has entered into an investment agreement (the “ [...]
Affimed Reports New Data for AFM13 from Two Separate Clinical Trials in Hodgkin and CD30-Positive Lymphomas
01/02/2018
Data Demonstrate AFM13 in Combination with Keytruda® (Pembrolizumab) Doubled Complete Response Rate in Hodgkin Lymphoma Patients Early Data Suggest New Opportunity for AFM13 in CD30-positive Lymphoma AFM13 is Clinically [...]
Corcept Therapeutics Announces Fourth Quarter and Full-Year 2017 Preliminary Selected Financial Results; Provides 2018 Revenue Guidance
01/02/2018
2017 revenue of $159.2 million, an increase of 96 percent from 2016 Fourth quarter revenue of $53.3 million, an increase of 124 percent from fourth quarter 2016 Cash and marketable securities at December 31, 2017 of $ [...]
Pivotal study reports InSure® FIT™ offers superior sensitivity for colorectal cancer screening
01/02/2018
BRIDGEWATER, N.J., Feb. 01, 2018 (GLOBE NEWSWIRE) -- Clinical Genomics, manufacturer of fecal immunochemical tests for colorectal cancer screening programs, announces that in a study of more than 1000 people screened [...]
Assure Holdings to Present at the 2018 World Outlook Financial Conference
01/02/2018
PARKER, Colo., Feb. 01, 2018 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (TSX-V: IOM ) (OTCQB:ARHH), a provider of intraoperative neuromonitoring services, will be participating in the 2018 [...]
Devonian Announces Acquisition of Altius Healthcare
01/02/2018
Transaction highlights: Provide Devonian sales and marketing bench strength Create a compelling financial and operational platform for future growth QUÉBEC CITY, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Devonian Health Group [...]
Devonian annonce l’acquisition de Altius Healthcare
01/02/2018
Faits saillants de la transaction: Procure des capacités de vente et de marketing à Devonian Création d’une plate-forme opérationnelle et financière probante pour la croissance future QUÉBEC, 01 févr. 2018 (GLOBE [...]

Pages